Korio, Inc. raised an undisclosed amount in a Series A funding led by BIP Ventures to accelerate the growth of its innovative Randomization & Trial Supply Management platform.

Sep 10, 2024•over 1 year ago

Round Type

series a

DoylestownInformation Technology

Investors

Boston Millennia PartnersExcelerate Health VenturesBip Ventures

Description

Korio, Inc. successfully completed its Series A funding round led by BIP Ventures, with participation from existing investors. This investment highlights strong customer demand for Korio's flexible and quality-focused RTSM platform.

Company Information

Company

Korio

Location

320 E. STATE STREET

Doylestown, Pennsylvania, United States

About

Korio is the industry’s leading compliance-centric Randomization & Trial Supply Management (RTSM) platform. Reflecting decades of hands-on experience across thousands of trial designs, Korio enables once aspirational goals around feature reusability, process repeatability, system performance, and overall system quality by embedding the latest RTSM design intelligence into our solution. Our intuitive approach to RTSM setup and management through a regulatory lens ensures audit-readiness and a predictable GxP compliant outcome on every clinical trial.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns